Targeting RAD51 enhances chemosensitivity of adult T‑cell leukemia‑lymphoma cells by reducing DNA double‑strand break

Meng Yang1, Xiaoxue Tian1, Zhuoyi Fan1

  • 1Department of Hematology, Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, P.R China.

Oncology Reports
|October 23, 2019
PubMed

Insights

Targeting RAD51, a key DNA repair protein, can sensitize adult T-cell leukemia-lymphoma cells to chemotherapy. Suppressing RAD51 enhances cancer cell death and may improve patient survival.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • RAD51 is a crucial homologous recombination protein involved in DNA repair, gene stability, and diversity.
  • Overexpression of RAD51 is linked to chemotherapy resistance in tumor cells.
  • Enhanced DNA damage repair (DDR) activity contributes to chemotherapy resistance in adult T-cell leukemia-lymphoma (ATL).

Purpose of the Study:

  • To investigate the potential of targeting RAD51 to sensitize ATL cells to chemotherapy.
  • To explore the role of RAD51 in DNA damage repair and its impact on ATL cell survival.
  • To evaluate the efficacy of RAD51 downregulation in combination with etoposide treatment.

Main Methods:

  • Utilized short hairpin RNA (shRNA) to downregulate RAD51 expression.
  • Administered imatinib to inhibit RAD51 activity.
  • Treated Jurkat cells (a model for ATL) with etoposide.
  • Assessed homologous recombination (HR) activity, cell proliferation, and apoptosis.

Main Results:

  • Downregulation of RAD51 by shRNA and imatinib sensitized Jurkat cells to etoposide by reducing HR activity.
  • Suppression of RAD51 inhibited tumor cell proliferation and increased apoptosis after etoposide treatment.
  • Imatinib-mediated RAD51 downregulation significantly enhanced etoposide-induced apoptosis in Jurkat cells.

Conclusions:

  • RAD51 is a promising therapeutic target for adult T-cell leukemia-lymphoma (ATL).
  • Targeting RAD51 can enhance the efficacy of chemotherapy by inducing DNA damage and promoting cancer cell death.
  • Inhibition of RAD51 may improve clinical outcomes and survival rates for leukemia patients.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
Fixing Double-strand Breaks02:04

Fixing Double-strand Breaks

The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
14.2K